The Indian Covid-19 vaccine manufacturers, the Serum Institute of India (SII) and Bharat Biotech, have been ordered by the Delhi High Court to file an affidavit stating the existing ability to produce vaccines and can it be expanded.
The court has also ordered the Central Ministry of Health and Family Welfare to file a report demonstrating its ability to transport the drug, specifically to the National Capital Territory of Delhi. “The reason for maintaining strict control on the class of individuals to be vaccinated shall also be disclosed in UOI’s declaration. The DHCBA and BCD must also file an affidavit about their capacity, according to the bench, which ordered that the documents be filed by March 9.
The court issued the directives while addressing a suo motu petition filed by the court on one’s own appeal to include judicial officers, advocates, and judges as frontline employees.
The suo motu cognizance was raised in response to a letter from the Chairman of the Delhi Bar Council requesting the relevant authorities to provide adequate guidance to provide facilities needed in Court premises for the vaccination of judicial officers by considering them as frontline staff.
The court added that “At the same time, we’re donating and selling it to other nations… but we’re not vaccinating our own citizens,”.
The court also stated in its order that, in light of the escalating pandemic, the need of the time is to immunize the populace on a war-footing in order to make sure the health and life of those who leave their homes to pursue their avocations and careers.